What is the definition of Postural Orthostatic Tachycardia Syndrome (POTS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Definition of POTS

POTS is a chronic autonomic disorder requiring both excessive orthostatic tachycardia (≥30 bpm heart rate increase within 10 minutes of standing in adults ≥20 years, or ≥40 bpm in adolescents 12-19 years) AND predominant bothersome orthostatic symptoms that improve with recumbence, persisting for at least 3 months, in the absence of orthostatic hypotension. 1

Core Diagnostic Criteria

POTS diagnosis requires meeting both hemodynamic and symptom criteria simultaneously:

Hemodynamic Requirements

  • Sustained heart rate increase from supine to upright position:
    • ≥30 bpm in adults (≥20 years old)
    • ≥40 bpm in adolescents (12-19 years old)
  • Measured within 10 minutes of standing or head-up tilt
  • No orthostatic hypotension (systolic BP drop <20 mmHg and diastolic BP drop <10 mmHg) 1, 2

Symptom Requirements

  • Predominant and bothersome orthostatic symptoms that must be the dominant clinical presentation
  • Symptoms improve or resolve with lying down (recumbence)
  • No single cardinal symptom or minimum number of symptoms required
  • Common manifestations include: lightheadedness, palpitations, fatigue, cognitive dysfunction ("brain fog"), exercise intolerance, nausea, bloating, and sleep disturbance 1, 2

Temporal Requirement

  • Symptoms and hemodynamic changes must be chronic, persisting ≥3 months 1

Critical Diagnostic Distinctions

The 2020 Canadian Cardiovascular Society guidelines emphasize that meeting only hemodynamic criteria without symptoms, or having symptoms without meeting heart rate criteria, does NOT constitute POTS 1. These are classified as:

  • Asymptomatic orthostatic tachycardia: Heart rate criteria met but patient is asymptomatic—this is NOT POTS
  • PSWT (Postural Symptoms Without Tachycardia): Symptoms present but heart rate criteria not met—this is NOT POTS
  • PTOC (Postural Tachycardia of Other Cause): Heart rate criteria met but clear secondary cause identified (prolonged bedrest, severe hypovolemia, medications)—this is NOT POTS

Essential Exclusions

Before diagnosing POTS, exclude alternative causes of sinus tachycardia:

  • Thyroid disease, adrenal insufficiency, pheochromocytoma
  • Cardiomyopathy, valvular or congenital heart disease
  • Chronic lung disease
  • Medications (stimulants, norepinephrine reuptake inhibitors, diuretics)
  • Anemia, dehydration
  • Inappropriate sinus tachycardia (IST)—which has different hemodynamic patterns 2, 3

Clinical Context

POTS predominantly affects females (~90% of cases) with peak incidence ages 13-29 years. In 30-40% of cases, symptoms begin within 3 months after infections (SARS-CoV-2, Epstein-Barr virus, influenza). Approximately 70% of patients report substantial functional impairment with median diagnostic delay of 24 months 2.

The diagnosis is purely clinical—there is no specific biomarker or imaging study that confirms POTS. The diagnosis rests entirely on documenting the characteristic hemodynamic response during orthostatic challenge while simultaneously confirming chronic orthostatic symptoms and excluding alternative diagnoses 1, 3.

Related Questions

I have hyperadrenergic postural orthostatic tachycardia syndrome (POTS) with controlled heart rate, but I still experience post‑prandial discomfort, tension, and feeling on edge after meals; how can I alleviate these symptoms?
What is the optimal management for a patient with orthostatic hypotension, supine hypertension, and postural orthostatic tachycardia syndrome (POTS)?
In a patient ≥20 years old with chronic orthostatic symptoms, does an increase of 33 beats per minute from supine to standing meet the heart‑rate criterion for postural orthostatic tachycardia syndrome (POTS)?
What non‑pharmacologic and pharmacologic strategies can I use to treat persistent morning sympathetic activation, palm and foot sweating, and discomfort on waking in a patient with hyperadrenergic postural orthostatic tachycardia syndrome (POTS) who previously experienced orthostatic and post‑prandial tachycardia?
What are the recommended management strategies for a patient with postural orthostatic tachycardia syndrome (POTS) who experiences light‑headedness during exercise?
How should I evaluate and manage a 26-year-old woman with five days of oppressive chest pain radiating to the left arm (8/10 intensity, reproducible on palpation, partially relieved by aspirin) and a one-month history of white, foul‑smelling vaginal discharge without itching or pelvic pain?
When should Monofer (iron isomaltoside/ferric derisomaltose) be used instead of Venofer (iron sucrose) in hospitalized patients?
What anti‑Xa activity range should be targeted for prophylactic low‑molecular‑weight heparin therapy?
What is the optimal oral antibiotic regimen for treating pelvic inflammatory disease in a lactating woman?
In a patient ≥20 years old with chronic orthostatic symptoms, does an increase of 33 beats per minute from supine to standing meet the heart‑rate criterion for postural orthostatic tachycardia syndrome (POTS)?
What conditions does alpha-fetoprotein (AFP) indicate, and what level of elevation is considered worrisome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.